An open label single centre study to Evaluate the Effectiveness of Q-Sera Hair Serum in Reducing Hair Fall in Telogen Effluvium Patients at 20th Day

An open labeled, single centered Study to determine the efficacy of Q – Sera Hair Serum in controlling hair fall within 20 days for Telogen Effluvium patients - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2024/10/075602

Enrollment

Registered

2024-10-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L650- Telogen effluvium

Interventions

Intervention1: Q-Sera Hair Serum: To apply 2ml of Q – Sera Hair Serum once daily in the evening for 12 weeks Control Intervention1: Capixyl, and Procapil 3% Combination: To apply 2ml of Capixyl, and P

Eligibility

Inclusion criteria

Inclusion criteria: 1.Males and females greater than 18 and less than 45 years of age 2.Subjects in good general health 3.Willingness to use Q – Sera Hair Serum and comply with product use as specified by the study doctor for the entire duration of the study 4.Ability to comprehend and follow the requirements of the study (including availability on scheduled visit dates) 5.Willingness to maintain the same hair style, approximate length and hair colour throughout the study 6.Patients will be naïve to treatment 7.Subjects willing to provide written informed consent

Exclusion criteria

Exclusion criteria: 1.Treatment with a systemic or locally acting medication which may interfere with the study objectives. 2.Known sensitivity to any investigational product ingredient 3.Subject who has participated in another clinical trial with hair product or treatment (local on the scalp and/or systemic) within the last 12 weeks before the selection visit

Design outcomes

Primary

Measure	Time frame
To determine the efficacy of Q – Sera Hair Serum in controlling hair fall within 20 days for Telogen Effluvium patients & having better efficacy over comparator products on certain parameters like Hair fall control, Hair Density, Thickness & Hair StrengthTimepoint: After 3 months	—

Secondary

Measure	Time frame
To determine the efficacy of Q – Sera Hair Serum in controlling hair fall within 20 days for Telogen Effluvium patients & having better efficacy over comparator products on certain parameters like Hair fall control, Hair Density, Thickness & Hair Strength at Visit1(Baseline), Visit 2(Day 20), Visit 3(Day 54) and Visit 4(Day 84).Timepoint: After 3 months	—

Countries

India

Contacts

Public ContactDr B S Chandrashekar

CUTIS Academy of Cutaneous Sciences

cutisclinic@gmail.com9740091155

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026